• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yoshimura Kazuhiro  吉村 一宏

ORCIDConnect your ORCID iD *help
… Alternative Names

YOSHIMURA Kazuhiro  吉村 一宏

Less
Researcher Number 20283757
Other IDs
Affiliation (Current) 2025: 近畿大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2014 – 2018: 近畿大学, 医学部, 教授
2010 – 2013: 近畿大学, 医学部, 准教授
2003 – 2004: 大阪大学, 医学系研究科, 講師
2002: 大阪大学, 医学系研究科, 助手
Review Section/Research Field
Principal Investigator
Urology
Except Principal Investigator
Urology
Keywords
Principal Investigator
Fibronectin / HGF / Calcium oxalate / Urolithiasis / GAGS / クエン酸 / LDH / アポトーシス / 蓚酸カルシウム結晶 / 蓚酸 / 蓚酸カルシウム / 尿路結石症 … More
Except Principal Investigator
… More 免疫療法 / ペプチドワクチン / 腎細胞癌 / PDL-1 / HIF-1 / EPOR / 癌ワクチン療法 / 腎細胞がん / 癌ワクチン / HLA-A2 / がんワクチン / HLA-A24 / ワクチン療法 / ペプチド / VEGFR / CA9 Less
  • Research Projects

    (4 results)
  • Research Products

    (15 results)
  • Co-Researchers

    (7 People)
  •  Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Development of multi-peptide tumor vaccine for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of tailor made peptide vaccines for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Investigation of inhibitors in crystal-cell injury of renal tubular epithelium by oxalate and calcium oxalatePrincipal Investigator

    • Principal Investigator
      YOSHIMURA Kazuhiro, 三宅 修
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Osaka University

All 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

  • [Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

    • Author(s)
      1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 44 Pages: 197-202

    • DOI

      10.1016/j.intimp.2017.01.014

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
  • [Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015

    • Author(s)
      Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
    • Journal Title

      Journal of Immunotherapy

      Volume: 38 (7) Issue: 7 Pages: 285-291

    • DOI

      10.1097/cji.0000000000000090

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      International Immunopharmacology

      Volume: 26 Issue: 1 Pages: 133-138

    • DOI

      10.1016/j.intimp.2015.03.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H.
    • Journal Title

      Br J Cancer.

      Volume: 108 Issue: 6 Pages: 1260-1266

    • DOI

      10.1038/bjc.2013.90

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H
    • Journal Title

      Br J Cancer

      Volume: 108(6) Pages: 1260-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.2013

    • Author(s)
      Yoshimura K, Uemura H. Yoshimura K, Uemura H.
    • Journal Title

      Int J Urol.

      Volume: - Issue: 8 Pages: 1-10

    • DOI

      10.1111/iju.12147

    • NAID

      10031190532

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
  • [Presentation] HLA-A24陽性腎細胞癌症例においてCancer-reactive cytotoxic T lymphocytes を誘導しうるEpoR, PD-L1ペプチドの同定2016

    • Author(s)
      南 高文、南 知子、清水信貴、山本 豊、Marco De Velasco、野澤昌弘、吉村一宏、
    • Organizer
      第104回日本泌尿器科学会総会
    • Place of Presentation
      仙台国際センター、東北大学記念会館、仙台市
    • Year and Date
      2016-04-23
    • Data Source
      KAKENHI-PROJECT-16H05466
  • [Presentation] 去勢抵抗性前立腺癌に対する免疫療法2015

    • Author(s)
      吉村一宏、植村天受 ほか
    • Organizer
      第65回 日本泌尿器科学会中部総会
    • Place of Presentation
      長良川国際会議場、岐阜都ホテル
    • Year and Date
      2015-10-23
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013

    • Author(s)
      T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
    • Organizer
      28th Annual EAU Congress
    • Place of Presentation
      Milan
    • Year and Date
      2013-03-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012

    • Author(s)
      南 高文、南 知子、大関孝之、デベラスコマルコ、清水信貴、山本 豊、辻 秀憲、野澤昌弘、吉村一宏、植村天受
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012

    • Author(s)
      植村天受、吉村一宏、南 高文、デベラスコ マルコ
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012

    • Author(s)
      Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
    • Organizer
      The 10th Annual Meeting of Japanese Society of Medical Oncology
    • Place of Presentation
      Osaka
    • Year and Date
      2012-07-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] 転移性腎癌に対するMHCクラスIペプチドワクチン療法の役割

    • Author(s)
      植村天受、吉村一宏ほか
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Data Source
      KAKENHI-PROJECT-22390305
  • 1.  DE VELASCO Marco (20449838)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 7 results
  • 2.  UEMURA Hirotsugu (90213397)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 12 results
  • 3.  MINAMI Takafumi (70340809)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 10 results
  • 4.  HARADA Mamoru (50260716)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 4 results
  • 5.  三宅 修 (60273661)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  辻畑 正雄 (30335343)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  原嶋 奈々江
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi